The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Biotechnology
Guilin Sanjin Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.08% CNY14.74
America/New_York / 5 mai 2024 @ 23:42
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 8 161.36 mill |
| EPS: | 0.600 |
| P/E: | 24.57 |
| Earnings Date: | May 16, 2024 |
| SharesOutstanding: | 553.69 mill |
| Avg Daily Volume: | 3.92 mill |
| RATING 2024-04-30 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.69x |
| Company: PE 24.57 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.84x |
| Company: PE 24.57 | industry: PE 29.29 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY35.03 (137.64%) CNY20.29 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 14.00 - 14.60 ( +/- 2.10%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY14.74 (3.08% ) |
| Volume | 3.63 mill |
| Avg. Vol. | 3.92 mill |
| % of Avg. Vol | 92.60 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 002275.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
002275.SZ
Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; and Naomaitai capsules, etc. It also produces TCM preparations. The company was founded in 1967 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.